Mark‐Oliver Zahn

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Frank Griesinger, Wilfried Eberhardt, Arnd Nusch et al. · Lung Cancer · 2020 · 83 citations · Full text

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Nadia Harbeck, Peter A. Fasching, Rachel Wuerstlein et al. · Annals of Oncology · 2023 · 39 citations · Full text

Real-World Evidence of NEPA, Netupitant-Palonosetron, in Chemotherapy-Induced Nausea and Vomiting Prevention: Effects on Quality of Life

Meinolf Karthaus, Gülten Oskay-Özcelik, P Wülfing et al. · Future Oncology · 2020 · 30 citations · Full text

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective <scp>QOLIXANE</scp> trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Alexander Reichart et al. · International Journal of Cancer · 2020 · 20 citations · Full text

Cancer Management, Pharmacotherapy, Metastatic Pancreatic Cancer +17

Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO

Jens Uhlig, Mark‐Oliver Zahn, Thomas Decker et al. · Oncology Research and Treatment · 2021 · 11 citations · Full text